Learn from people with more than 10 years of experience

Medication Non-Adherence in Rheumatology, Oncology and Cardiology: A Review of the Literature of Risk Factors and Potential Interventions

Aad Liefveld
80 (updated: 15-11-2022 18:46)
medication-non-adherence-in-rheumatology-oncology-and-cardiology-151118464410.jpg
31-10-2022 13:32

Medication Non-Adherence in Rheumatology, Oncology and Cardiology: A Review of the Literature of Risk Factors and Potential Interventions

 

A very interesting read, shared by our BEAMER colleagues at Pfizer. It identifies not only risk factors for adherence in three disease areas, but also the potentially most effective interventions to improve adherence. The conclusions of this 2022 publication are fully in line with our rationale in 2017 to start developing our Adherence Risk Management (ARM) services for clinical studies.

 

Read more

Like or Share

link2trials

Tell us more. Solutions from Link2Trials go one step further. Let us know your goals

Thank you we will contact you soon
An error occurred. Please try again

Link2Trials

  • 1223 HL Hilversum
  • The Netherlands
  • Chamber of Commerce: 32122355

Privacy statement

beamer
eu
imi
efpia